Author:
Kenneally Martin,Lynch Brenda
Publisher
Springer Science and Business Media LLC
Subject
Health Policy,Economics, Econometrics and Finance (miscellaneous)
Reference26 articles.
1. Barry, M., Molloy, D., Usher, C., Tilson, L.: Drug expenditure in Ireland. IMJ 102(6), 289–302 (2009)
2. Buckley, G., Kenneally, M., Walshe, V.: Variations in the average cost of GMS medicines in Ireland. Centre for policy studies. Working Paper; CPS-WP, pp 13–008. http://www.ucc.ie/en/policystudies/workingpapers/ (2013). Accessed 01 Apr 2017
3. Hellerstein, J.K.: The importance of the physician in the generic versus trade-name prescription decision. RAND J. Econ. 29, 108–136 (1998)
4. Anastasaki, E., Bradshaw, S., Proach, A., Shah, S.: The Greek healthcare reform after troika: the potential impact on global pricing and access strategy. In: ISPOR 17th Annual European Congress, Amsterdam. http://mktxs.com/wp-content/uploads/2014/10/PHP152-The-Greek-Healthcare-Reform-After-Troikas-Involvement-The-Potential-Impact-on-Global-Pricing-and-Access-Strategy-by-Eirini-Anastasaki-Steven-Bradshaw-Sandip-Shah.pdf (2014). Accessed 21 Mar 2017
5. Tilson, L., Bennett, K., Barry, M.: The potential impact of implementing a system of generic substitution on the community drug schemes in Ireland. Eur. J. Health Econ. 505, 267–273 (2005)
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献